Hemostemix Stock Market Value
| HMTXF Stock | USD 0.06 0.0004 0.64% |
| Symbol | Hemostemix |
Hemostemix 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Hemostemix's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Hemostemix.
| 09/28/2025 |
| 12/27/2025 |
If you would invest 0.00 in Hemostemix on September 28, 2025 and sell it all today you would earn a total of 0.00 from holding Hemostemix or generate 0.0% return on investment in Hemostemix over 90 days. Hemostemix is related to or competes with Prenetics Global, Nuwellis, P3 Health, Dermata Therapeutics, Aclarion, and Purple Biotech. Hemostemix Inc., a biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies f... More
Hemostemix Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Hemostemix's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Hemostemix upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 20.26 | |||
| Value At Risk | (8.76) | |||
| Potential Upside | 6.56 |
Hemostemix Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hemostemix's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Hemostemix's standard deviation. In reality, there are many statistical measures that can use Hemostemix historical prices to predict the future Hemostemix's volatility.| Risk Adjusted Performance | 0.0011 | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (0.47) | |||
| Treynor Ratio | (0.06) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Hemostemix's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hemostemix Backtested Returns
Hemostemix holds Efficiency (Sharpe) Ratio of -0.0258, which attests that the entity had a -0.0258 % return per unit of risk over the last 3 months. Hemostemix exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Hemostemix's Risk Adjusted Performance of 0.0011, market risk adjusted performance of (0.05), and Standard Deviation of 3.96 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.81, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Hemostemix's returns are expected to increase less than the market. However, during the bear market, the loss of holding Hemostemix is expected to be smaller as well. At this point, Hemostemix has a negative expected return of -0.1%. Please make sure to check out Hemostemix's variance, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Hemostemix performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.36 |
Below average predictability
Hemostemix has below average predictability. Overlapping area represents the amount of predictability between Hemostemix time series from 28th of September 2025 to 12th of November 2025 and 12th of November 2025 to 27th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Hemostemix price movement. The serial correlation of 0.36 indicates that just about 36.0% of current Hemostemix price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.36 | |
| Spearman Rank Test | 0.12 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Hemostemix lagged returns against current returns
Autocorrelation, which is Hemostemix otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Hemostemix's otc stock expected returns. We can calculate the autocorrelation of Hemostemix returns to help us make a trade decision. For example, suppose you find that Hemostemix has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Hemostemix regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Hemostemix otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Hemostemix otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Hemostemix otc stock over time.
Current vs Lagged Prices |
| Timeline |
Hemostemix Lagged Returns
When evaluating Hemostemix's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Hemostemix otc stock have on its future price. Hemostemix autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Hemostemix autocorrelation shows the relationship between Hemostemix otc stock current value and its past values and can show if there is a momentum factor associated with investing in Hemostemix.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Hemostemix OTC Stock
Hemostemix financial ratios help investors to determine whether Hemostemix OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hemostemix with respect to the benefits of owning Hemostemix security.